Evidence map›Paper›PMID 35893283›Full record

ReviewNeurology international2022

Sudden Unexpected Death in Epilepsy.

Teri B O'Neal, Sanjay Shrestha, Harsimar Singh, Ihianle Osagie, Kenechukwu Ben-Okafor, Elyse M Cornett, Alan D Kaye

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Neurology international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07116421 (Effect of 2-phenylethanol Odor Exposure on Ictal Apneic Episode Occurrence Rate in Patients With Epilepsy), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07116421 early_phase1recruitingnot on this mapstarted 2025, after this paper: background citation

Effect of 2-phenylethanol Odor Exposure on Ictal Apneic Episode Occurrence Rate in Patients With Epilepsy

TypeinterventionalSponsorVanderbilt University Medical CenterRan2025 to 2027Enrolled40ConditionsEpilepsy, Sudden Unexpected Death in EpilepsyArms2-phenylethanol rose scent
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Review
  5. Epilepsy in Asian countries.Acta epileptologica · 2023
    Review
  6. Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Teri B O'NealDepartment of Family Medicine, LSU Health Shreveport/Monroe Medical Center, Monroe, LA 71202, USA.
Sanjay ShresthaDepartment of Family Medicine, LSU Health Shreveport/Monroe Medical Center, Monroe, LA 71202, USA.ORCID 0000-0003-4948-1039
Harsimar SinghDepartment of Family Medicine, LSU Health Shreveport/Monroe Medical Center, Monroe, LA 71202, USA.
Ihianle OsagieDepartment of Family Medicine, LSU Health Shreveport/Monroe Medical Center, Monroe, LA 71202, USA.
Kenechukwu Ben-OkaforDepartment of Family Medicine, LSU Health Shreveport/Monroe Medical Center, Monroe, LA 71202, USA.
Elyse M CornettDepartment of Anesthesiology, Louisiana State University Health Shreveport, Shreveport, LA 71103, USA.ORCID 0000-0001-7961-3931
Alan D KayeDepartment of Anesthesiology, Louisiana State University Health Shreveport, Shreveport, LA 71103, USA.
Louisiana State University Health Sciences Center Shreveport · USLouisiana State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epilepsy is a complex neurological condition with numerous etiologies and treatment options. In a subset of these patients, sudden unexpected death can occur, and to date, there are numerous explanations as to the pathophysiological mechanisms and how to mitigate these catastrophic outcomes. Approximately 2.3 million Americans have epilepsy, and nearly 150,000 people develop the condition each year. Sudden unexpected death in epilepsy (SUDEP) accounts for 2-18% of all epilepsy-related deaths and this is equivalent to one death in 1000 person-years of diagnosed epilepsy. It is more common in young adults aged 20-45. Seizures in the past year; the absence of terminal remission in the last five years; increased seizure frequency, particularly GTCS; and nocturnal seizures are the most potent modifiable risk factors for SUDEP. Patients not receiving any antiepileptic drug therapy are at higher risk of SUDEP. Patient education on medication compliance; care plans for seizure clusters (rescue medicines); epilepsy self-management programs; and lifestyle changes to avoid seizure-triggering factors, including avoiding excessive alcohol use and sleep deprivation, should be provided by health care providers. Continued research into SUDEP will hopefully lead to effective interventions to minimize occurrences. At present, aggressive control of epilepsy and enhanced education for individuals and the public are the most effective weapons for combating SUDEP. This narrative review focuses on updated information related to SUDEP epidemiology; pathophysiology; risk factor treatment options; and finally, a discussion of important clinical studies. We seek to encourage clinicians who care for patients with epilepsy to be aggressive in controlling seizure activity and diligent in their review of risk factors and education of patients and their families about SUDEP.

Indexed as

arrythmiacardiac arrestcounselingeducationepilepsysudden deathTakotsubo cardiomyopathy

Identifiers

PMID35893283
PMCPMC9326725
OpenAlexW4285731165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.